Chapter 23 Involvement of Endocannabinoid Signaling in the Neuroprotective Effects of Subtype 1 Metabotropic Glutamate Receptor Antagonists in Models of Cerebral Ischemia

International Review of Neurobiology

Volumn 85, Issue , 2009, Pages 337-350

  Landucci, Elisa ^a   Boscia, Francesca ^b   Gerace, Elisabetta ^a   Scartabelli, Tania ^a   Cozzi, Andrea ^a   Moroni, Flavio ^a   Mannaioni, Guido ^a   Pellegrini Giampietro, Domenico E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; 3 METHYL AMINOTHIOPHENE DICARBOXYLIC ACID; 4 AMINOBUTYRIC ACID; ENDOCANNABINOID; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR;

BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HIPPOCAMPUS; INTERNEURON; NERVE CELL LESION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; ANIMAL; BIOLOGICAL MODEL; DRUG ANTAGONISM; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN ISCHEMIA; ENDOCANNABINOIDS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MODELS, BIOLOGICAL; NEURONS; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 67650082990     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(09)85023-X     Document Type: Review

References (63)

1. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoids. Prog. Neurobiol. 68 (2002) 247-286
2. Bao W.L., Williams A.J., Faden A.I., and Tortella F.C. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res. 922 (2001) 173-179
3. Battaglia G., Bruno V., Pisani A., Centonze D., Catania M.V., Calabresi P., and Nicoletti F. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Mol. Cell. Neurosci. 17 (2001) 1071-1083
4. Baude A., Nusser Z., Roberts J.D.B., Mulvihill E., McIlhinney R.A.J., and Somogyi P. The metabotropic glutamate receptor (mGluR1α) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 11 (1993) 771-787
5. Berthele A., Laurie D.J., Platzer S., Zieglgansberger W., Tolle T.R., and Sommer B. Differential expression of rat and human type I metabotropic glutamate receptor splice variant messenger RNAs. Neuroscience 85 (1998) 733-749
6. Blasco-Ibáñez J.M., and Freund T.F. Synaptic input of horizontal interneurons in stratum oriens of the hippocampal CA1 subfield: Structural basis of feed-back activation. Eur. J. Neurosci. 7 (1995) 2170-2180
7. Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N., and Freund T.F. Endocannabinoid signaling in rat somatosensory cortex: Laminar differences and involvement of specific interneuron types. J. Neurosci. 25 (2005) 6845-6856
8. Bordi F., and Ugolini A. Group I metabotropic glutamate receptors: Implications for brain diseases. Prog. Neurobiol. 59 (1999) 55-79
9. Boscia F., Ferraguti F., Annunziato L., Moroni F., and Pellegrini-Giampietro D.E. mGlu1α receptors are co-expressed with CB1 receptors in a subset of interneurons in the CA1 region of organotypic hippocampal slice cultures and adult rat brain. Neuropharmacology 55 (2008) 428-439
10. Bruno V., Battaglia G., Kingston A.E., O'Neill M.J., Catania M.V., Di Grezla R., and Nicoletti F. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY367385): Comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology 38 (1999) 199-207
11. Chen K., Neu A., Howard A.L., Foldy C., Echegoyen J., Hilgenberg L., Smith M., Mackie K., and Soltesz I. Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci. 27 (2007) 46-58
12. Chevaleyre V., and Castillo P.E. Heterosynaptic LTD of hippocampal GABAergic synapses. A novel role of endocannabinoids in regulating excitability. Neuron 38 (2003) 461-472
13. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29 (2006) 37-76
14. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6 (1996) 667-672
15. 2+ -channels involves multiple receptor subtypes in cortical neurons. J. Neurosci. 16 (1996) 36-45
16. Conn P.J., and Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
17. Cope D.W., Maccaferri G., Marton L.F., Roberts J.D., Cobden P.M., and Somogyi P. Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 109 (2002) 63-80
18. Cozzi A., Meli E., Carlà V., Moroni F., and Pellegrini-Giampietro D.E. Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: A mechanism for the attenuation of post-ischemic injury and epileptiform activity?. Neuropharmacology 43 (2002) 119-130
19. De Vry J., Horvath E., and Schreiber R. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620. Eur. J. Pharmacol. 428 (2001) 203-214
20. Doherty J., and Dingledine R. Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. Curr. Opin. Pharmacol. 3 (2003) 46-53
21. Ferraguti F., Conquet F., Corti C., Grandes P., Kuhn R., and Knoepfel T. Immunohistochemical localization of the mGluR1β metabotropic glutamate receptor in the adult rodent forebrain: Evidence for a different distribution of mGluR1 splice variants. J. Comp. Neurol. 400 (1998) 391-407
22. Ferraguti F., Cobden P., Pollard M., Cope D., Shigemoto R., Watanabe M., and Somogyi P. Immunolocalization of metabotropic glutamate receptor 1α (mGluR1α) in distinct classes of interneurons in the CA1 region of rat hippocampus. Hippocampus 14 (2004) 193-215
23. Fiorillo C.D., and Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 394 (1998) 78-82
24. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
25. Gasparini F., Kuhn R., and Pin J.P. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr. Opin. Pharmacol. 2 (2002) 43-49
26. Gereau IV R.W., and Conn P.J. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. J. Neurosci. 15 (1995) 6879-6889
27. Hajos N., Katona I., Naiem S.S., Mackie K., Ledent C., Mody I., and Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12 (2000) 3239-3249
28. Henrich-Noack P., Hatton C.D., and Reymann K.G. The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils. NeuroReport 9 (1998) 985-988
29. Hubert G.W., Paquet M., and Smith Y. Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey substantia nigra. J. Neurosci. 21 (2001) 1838-1847
30. Kano M., Ohno-Shosaku T., and Maejima T. Retrograde signaling at central synapses via endogenous cannabinoids. Mol. Psychiatry 7 (2002) 234-235
31. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., and Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19 (1999) 4544-4558
32. Kosaka T., Kosaka K., Tateishi K., Hamaoka Y., Yanaihara N., Wu J.Y., and Hama K. GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus. J. Comp. Neurol. 239 (1985) 420-430
33. Luján R., Nusser Z., Roberts J.D.B., Shigemoto R., and Somogyi P. Perisynaptic localization of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 8 (1996) 1488-1500
34. Manahan-Vaughan D., Herrero I., Reymann K.G., and Sánchez-Prieto J. Presynaptic group 1 metabotropic glutamate receptors may contribute to the expression of long-term potentiation in the hippocampal CA1 region. Neuroscience 94 (1999) 71-82
35. Mannaioni G., Carlà V., and Moroni F. Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations. Br. J. Pharmacol. 118 (1996) 1530-1536
36. Mannaioni G., Marino M.J., Valenti O., Traynelis S.F., and Conn P.J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J. Neurosci. 21 (2001) 5925-5934
37. Marino M.J., Wittmann M., Bradley S.R., Hubert G.W., Smith Y., and Conn P.J. Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. J. Neurosci. 15 (2001) 7001-7012
38. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F.E., and Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46 (1998) 281-309
39. Meli E., Picca R., Attucci S., Cozzi A., Peruginelli F., Moroni F., and Pellegrini-Giampietro D.E. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo. Pharmacol. Biochem. Behav. 73 (2002) 439-446
40. Morishita W., Kirov S.A., and Alger B.E. Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1. J. Neurosci. 18 (1998) 4870-4882
41. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Albani Torregrossa S., Pellegrini-Giampietro D.E., Luneia R., and Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J. Pharmacol. Exp. Ther. 281 (1997) 721-729
42. 1 type receptors potentiate transmitter output in the rat cortex. Eur. J. Pharmacol. 347 (1998) 189-195
43. Moroni F., Attucci S., Cozzi A., Meli E., Picca R., Scheideler M.A., Pellicciari R., Noe C., Sarichelou I., and Pellegrini-Giampietro D.E. The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology 42 (2002) 741-751
44. Muralikrishna Rao A., Hatcher J.F., and Dempsey R.J. Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil. Neurosci. Lett. 293 (2000) 1-4
45. Neu A., Foldy C., and Soltesz I. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J. Physiol. 578 (2007) 233-247
46. Nicoletti F., Bruno V., Catania M.V., Battaglia G., Copani A., Barbagallo G., Ceña V., Sánchez-Prieto J., Spano P.F., and Pizzi M. Group-I metabotropic glutamate receptors: Hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology 38 (1999) 1477-1484
47. Ohno-Shosaku T., Maejima T., and Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29 (2001) 729-738
48. Ohno-Shosaku T., Shosaku J., Tsubokawa H., and Kano M. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur. J. Neurosci. 15 (2002) 953-961
49. Pellegrini-Giampietro D.E. The distinct role of mGlu1 receptors in post-ischemic neuronal death. Trends Pharmacol. Sci. 24 (2003) 461-470
50. Pellegrini-Giampietro D.E., Cozzi A., Peruginelli F., Leonardi P., Meli E., Pellicciari R., and Moroni F. 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3′-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia. Eur. J. Neurosci. 11 (1999) 3637-3647
51. Pellegrini-Giampietro D.E., Peruginelli F., Meli E., Cozzi A., Albani Torregrossa S., Pellicciari R., and Moroni F. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: Time-course and mechanisms. Neuropharmacology 38 (1999) 1607-1619
52. Pellicciari R., Raimondo M., Marinozzi M., Natalini B., Costantino G., and Thomsen C. (S)-(+)-2-(3′-Carboxybicyclo[1.1.1]pentyl)-glycine, a structurally new group I metabotropic glutamate receptor antagonist. J. Med. Chem. 39 (1996) 2874-2876
53. Rae M.G., and Irving A.J. Both mGluR1 and mGluR5 mediate Ca2+ release and inward currents in hippocampal CA1 pyramidal neurons. Neuropharmacology 46 (2004) 1057-1069
54. Rauca C., Henrich-Noack P., Schäfer K., Höllt V., and Reymann K.G. (S)-4C3HPG reduces infarct size after focal cerebral ischemia. Neuropharmacology 37 (1998) 1649-1652
55. Riedel G., and Reymann K.G. Metabotropic glutamate receptors in hippocampal long-term potentiation and learning and memory. Acta Physiol. Scand. 157 (1996) 1-19
56. Romano C., Sesma M.A., McDonald C.T., O'Malley K., van den Pol A.N., and Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 355 (1995) 455-469
57. Schwartz-Bloom R.D., and Sah R. γ-Aminobutyric acidA neurotransmission and cerebral ischemia. J. Neurochem. 77 (2001) 353-371
58. Somogyi J., Baude A., Omori Y., Shimizu H., El Mestikawy S., Fukaya M., Shigemoto R., Watanabe M., and Somogyi P. GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat. Eur. J. Neurosci. 19 (2004) 552-569
59. Stinehelfer S., Vruwink M., and Burette A. Immunolocalization of mGluR1alpha in specific populations of local circuit neurons in the cerebral cortex. Brain Res. 861 (2000) 37-44
60. Tallaksen-Greene S.J., Kaatz K.W., Romano C., and Albin R.L. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 780 (1998) 210-217
61. Tsou K., Mackie K., Sañudo-Peña M.C., and Walker J.M. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing gabaergic interneurons in the rat hippocampal formation. Neuroscience 93 (1999) 969-975
62. Varma N., Carlson G.C., Ledent C., and Alger B.E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci. 21 (2001) RC188
63. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592